DGAP-CMS: QIAGEN N.V.: Release of a capital market information

2021. szeptember 07., kedd, 09:51







DGAP Post-admission Duties announcement: QIAGEN N.V.


/ Share Repurchase






QIAGEN N.V.: Release of a capital market information








07.09.2021 / 09:51



Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG.


The issuer is solely responsible for the content of this announcement.




Disclosure according to Article 5 Section (1) and (6) of the EU Regulation 596/2014 in conjunction with Article 2 Section (2) and (3) of the Delegated EU Regulation 2016/1052 / Share Repurchase - Interim Reporting



With disclosure dated July 20, 2021, QIAGEN N.V. announced pursuant to Article 5 Section (1) and (6) of the EU Regulation no 596/2014 and Article 2 Section (1) of the Delegated EU Regulation no 2016/1052 the immediate beginning of a first tranche of up to USD 100 million under the share repurchase program originally announced on July 12, 2021.



The number of shares which have been bought back within the framework of such tranche of the share repurchase program in the time period from August 30, 2021 until and including September 3, 2021, amounts to 130,081 shares.



Shares were bought back as follows:































Date Number of Shares acquired Average Price (EUR) Purchased Volume (EUR)
30- August -2021 5,243 47.2655 247,813.02
31- August -2021 29,984 47.2487 1,416,705.02
1- September -2021 35,000 47.0356 1,646,246.00
2- September -2021 30,000 47.7045 1,431,135.00
3- September -2021 29,854 47.4916 1,417,814.23
Total 130,081 47.3529 6,159,713.26

 

The underlying individual trades are published on the website of QIAGEN N.V. (http://corporate.qiagen.com/investor-relations/share-information/share-buyback).



The total number of shares which have already been bought back within the framework of such tranche of the share repurchase program from July 20, 2021 until and including September 3, 2021 amounts to 1,176,821 shares.



The purchase of the shares of QIAGEN N.V. was carried out by a financial institution that has been commissioned by QIAGEN N.V.



Venlo, 7 September 2021



Managing Board



###
Contacts:



QIAGEN















Investor Relations   Public Relations  
John Gilardi +49 2103 29 11711 Dr. Thomas Theuringer +49 2103 29 11826
e-mail: ir@qiagen.com   e-mail: pr@qiagen.com  














07.09.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de













Language: English
Company: QIAGEN N.V.

Hulsterweg 82

5912 PL Venlo

Netherlands
Internet: www.qiagen.com





 
End of News DGAP News Service





1231693  07.09.2021 



fncls.ssp?fn=show_t_gif&application_id=1231693&application_name=news&site_id=geo_holding_tug
Tilos a hír bármilyen adatbázisba történő mentése vagy annak továbbítása harmadik fél számára;kereskedelmi viszonylatban vagy kereskedelmi céllal csak a Deutsche Gesellschaft für Ad-hoc-Publizität mbh írásos engedélyével történhet.

Közzétételek - archívum